These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 29983380)

  • 21. Sentinel node biopsy after neoadjuvant chemotherapy in cytologically proven node-positive breast cancer.
    Yagata H; Yamauchi H; Tsugawa K; Hayashi N; Yoshida A; Kajiura Y; In R; Matsuda N; Nakamura S
    Clin Breast Cancer; 2013 Dec; 13(6):471-7. PubMed ID: 24267732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexploring and overtreating the axilla.
    Galimberti V; Corso G; Monti S; Pagani G
    Breast; 2017 Feb; 31():290-294. PubMed ID: 27282983
    [No Abstract]   [Full Text] [Related]  

  • 23. Management of axillary disease.
    Caudle AS; Cupp JA; Kuerer HM
    Surg Oncol Clin N Am; 2014 Jul; 23(3):473-86. PubMed ID: 24882346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Novel Less-invasive Approach for Axillary Staging After Neoadjuvant Chemotherapy in Patients With Axillary Node-positive Breast Cancer by Combining Radioactive Iodine Seed Localization in the Axilla With the Sentinel Node Procedure (RISAS): A Dutch Prospective Multicenter Validation Study.
    van Nijnatten TJA; Simons JM; Smidt ML; van der Pol CC; van Diest PJ; Jager A; van Klaveren D; Kam BLR; Lobbes MBI; de Boer M; Verhoef K; Koppert LB; Luiten EJT
    Clin Breast Cancer; 2017 Aug; 17(5):399-402. PubMed ID: 28487053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection.
    Caudle AS; Yang WT; Krishnamurthy S; Mittendorf EA; Black DM; Gilcrease MZ; Bedrosian I; Hobbs BP; DeSnyder SM; Hwang RF; Adrada BE; Shaitelman SF; Chavez-MacGregor M; Smith BD; Candelaria RP; Babiera GV; Dogan BE; Santiago L; Hunt KK; Kuerer HM
    J Clin Oncol; 2016 Apr; 34(10):1072-8. PubMed ID: 26811528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes.
    Diego EJ; McAuliffe PF; Soran A; McGuire KP; Johnson RR; Bonaventura M; Ahrendt GM
    Ann Surg Oncol; 2016 May; 23(5):1549-53. PubMed ID: 26727919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of sentinel lymph node biopsy in breast cancer women N1-N2 with complete axillary response after neoadjuvant chemotherapy. Multicentre study in Tarragona.
    Carrera D; de la Flor M; Galera J; Amillano K; Gomez M; Izquierdo V; Aguilar E; López S; Martínez M; Martínez S; Serra JM; Pérez M; Martin L
    Rev Esp Med Nucl Imagen Mol; 2016; 35(4):221-5. PubMed ID: 26848141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic review of targeted axillary dissection in node-positive breast cancer treated with neoadjuvant systemic therapy: variation in type of marker and timing of placement.
    de Wild SR; Koppert LB; van Nijnatten TJA; Kooreman LFS; Vrancken Peeters MTFD; Smidt ML; Simons JM
    Br J Surg; 2024 Mar; 111(3):. PubMed ID: 38531689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Axillary surgery in breast cancer: the beginning of the end.
    Dumitru D; Khan A; Catanuto G; Rocco N; Nava MB; Benson JR
    Minerva Chir; 2018 Jun; 73(3):314-321. PubMed ID: 29589679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Axillary staging prior to or after neoadjuvant systemic therapy? A single institutional experience.
    Al Mushawah F; Tan MC; Margenthaler JA
    J Surg Oncol; 2010 Oct; 102(5):404-7. PubMed ID: 20082352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer with axillary node metastasis: A survey of clinical practice.
    Lee SB; Yu JH; Park H; Kim HJ; Park SH; Chae BJ; Youn HJ; Jung SY; Kim EK; Jung YS; Son BH
    Asian J Surg; 2019 Jan; 42(1):314-319. PubMed ID: 30049563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of the axilla after neoadjuvant chemotherapy for clinically node positive breast cancer: A nationwide survey study in The Netherlands.
    Vugts G; Maaskant-Braat AJ; de Roos WK; Voogd AC; Nieuwenhuijzen GA
    Eur J Surg Oncol; 2016 Jul; 42(7):956-64. PubMed ID: 27107791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Breast and Axillary Lymph Node Specimens in Breast Cancer Patients Treated With Neoadjuvant Systemic Therapy.
    Baker GM; King TA; Schnitt SJ
    Adv Anat Pathol; 2019 Jul; 26(4):221-234. PubMed ID: 31149907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intermediary clip placement to assist accurate axillary lymph node localization.
    Price ER; Vyas S; Lee AY; Wong JM; Joe BN; Ray KM
    Clin Imaging; 2021 May; 73():96-100. PubMed ID: 33352497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving the Accuracy of Axillary Lymph Node Surgery in Breast Cancer with Ultrasound-Guided Wire Localization of Biopsy Proven Metastatic Lymph Nodes.
    Plecha D; Bai S; Patterson H; Thompson C; Shenk R
    Ann Surg Oncol; 2015 Dec; 22(13):4241-6. PubMed ID: 25814365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controversies and recommendations regarding sentinel lymph node biopsy in primary breast cancer: A comprehensive review of current data.
    Charalampoudis P; Markopoulos C; Kovacs T
    Eur J Surg Oncol; 2018 Jan; 44(1):5-14. PubMed ID: 29174281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted axillary dissection and sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy - a retrospective study.
    Coufal O; Zapletal O; Gabrielová L; Fabian P; Schneiderová M
    Rozhl Chir; 2018; 97(12):551-557. PubMed ID: 30646734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Axillary Management: How Much Is Too Much?
    Owusu-Brackett N; Facer B; Quiroga D; Pariser A; Grimm M; Beyer S; Jhawar S; Oppong BA
    Curr Oncol Rep; 2024 Jul; 26(7):735-743. PubMed ID: 38748364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultrasound-Guided Restaging and Localization of Axillary Lymph Nodes After Neoadjuvant Chemotherapy for Guidance of Axillary Surgery in Breast Cancer Patients: Experience with Activated Charcoal.
    Kim WH; Kim HJ; Jung JH; Park HY; Lee J; Kim WW; Park JY; Chae YS; Lee SJ
    Ann Surg Oncol; 2018 Feb; 25(2):494-500. PubMed ID: 29134374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.